Astellas Pharma reported JPY3.91B in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Astellas Pharma JPY 3.91B 320M Mar/2025
Chugai Pharma JPY 95M 260M Dec/2025
Daiichi Sankyo JPY 3.57B 1.4B Mar/2026
Eisai JPY 1.96B 409M Jun/2026
Kyowa Hakko Kirin JPY 2.27B 1.84B Mar/2026
M3 JPY 259M 31M Mar/2026
Otsuka Holdings JPY 2.21B 866M Dec/2025
Shionogi JPY 5.32B 2.48B Jun/2026
Sumitomo Dainippon JPY 460M 15.14B Mar/2026
Takeda JPY 63.85B 20.2B Jun/2026
Terumo JPY 1.53B 1.06B Mar/2026